Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 4 Breast Neoplasms 3 Ovarian Neoplasms 2 Lung Neoplasms 2 Fatigue 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Disease Progression 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Adolescent and Young Adult Cancer Patient 1

Interventions

Cisplatin 13 Radiotherapy, Intensity-Modulated 11 Radiotherapy 5 Carboplatin 5 Radiation 4 Cetuximab 4 durvalumab 3 Platinum 3 Nivolumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Specimen Handling 2 Restraint, Physical 2 Paclitaxel 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Bupropion 2 Biopsy 2 Acupuncture Therapy 2 veliparib 1 utomilumab 1 sodium thiosulfate 1 ficlatuzumab 1 dehydroftorafur 1 Varenicline 1 Transcutaneous Electric Nerve Stimulation 1 Tobacco Use Cessation Devices 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Oropharyngeal Neoplasms × Palliative Care × Clear all

NCT04952922 2025-08-08

FUNQOLR

Royal Marsden NHS Foundation Trust

25 enrolled 8 charts

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡